Thermo Fisher Advances Gene Therapy with DeltaV Automation

Thermo Fisher

Prajakta Bhanap of Thermo Fisher Scientific discussed the company’s creation of Cellmation, a digital solution that dramatically streamlines the manufacture of cell therapies. For decades, the foundations of cancer treatment have been surgery, chemotherapy and radiation therapy. These continue to be critical mainstays of treatment, but in recent years new categories of treatment have helped transform the treatment outlook for many people with cancer.

Latest News

Emerson Releases 2023 Sustainability Report

Global technology and software company Emerson (NYSE: EMR) released its 2023 Sustainability Report today, highlighting the company’s efforts to...

Calvin Butler to Join Emerson’s Board of Directors

Emerson today announced the appointment of Calvin Butler to its Board of Directors, effective August 1, 2024.

Emerson’s Transformative GenAI Automation Delivers Powerful New Tool for Power and Water Industries

Ovation Automation Platform with GenAI will empower workforce, optimize operations
Please enable JavaScript to use this website.